Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Diclofenac Sodium Gel 3% (Actavis) to Solaraze ® (Diclofenac Sodium) Gel 3% (Fougera Pharms) in the Treatment of Actinic Keratosis
Conditions
Interventions
Diclofenac sodium
Placebo
Locations
31
United States
Investigator Site 23
Fremont, California, United States
Investigator Site 9
Long Beach, California, United States
Investigator Site 12
Newport Beach, California, United States
Investigator Site 2
San Diego, California, United States
Investigator Site 24
San Ramon, California, United States
Investigator Site 14
Denver, Colorado, United States
Start Date
March 1, 2013
Primary Completion Date
September 1, 2013
Completion Date
September 1, 2013
Last Updated
July 20, 2020
NCT07340697
NCT06778434
NCT07137819
NCT06648447
NCT05688904
NCT07286318
Lead Sponsor
Actavis Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions